Lung Cancer News

Discovery of coronary artery calcium in patients with non-small cell lung cancer undergoing thoracic radiation was associated with elevated risk for MI and stroke, even when found in small amounts, researchers reported.

The FDA should not make a regulatory decision on sintilimab for advanced lung cancer until additional study demonstrates applicability to U.S. patients, an advisory committee determined.

Cancer clinical trials supporting FDA approvals significantly differ in reporting of withdrawal of consent or loss to follow-up and early drug discontinuation for adverse events, according to study results.

American Association for Cancer Research released a first-of-its-kind report detailing the impact of the COVID-19 pandemic on the cancer community, both in patient care and research practice.

The U.S. Preventive Services Task Force’s 2021 guideline for lung cancer screening improved upon previous fixed-screening criteria and may reduce racial disparities in access, according to a study published in JAMA Oncology.

Cancer cell-derived or allergic reaction-released histamine dampened antitumor immunity and conferred resistance to cancer immunotherapy, according to a retrospective study published in Cancer Cell.

Patients with cancer had few differences in reported adverse events compared with people without cancer after receiving COVID-19 vaccines, according to study results published in JNCCN — Journal of the National Comprehensive Cancer Network.

Older patients with cancer benefited from single-agent immune checkpoint inhibitors but had higher rates of adverse events and therapy discontinuation with increasing age, according to results of a retrospective study in JAMA Oncology.

Germline microRNA-based biomarkers accurately predicted grade 2 or higher immune-related adverse events associated with anti-PD-1/PD-L1 therapy among patients with various cancer types, according to study results.

Studies funded by pharmaceutical companies appeared significantly more likely to find oncology drugs cost-effective than studies without such funding, according to results of a cross-sectional study published in JAMA Network Open.